Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Cash Flow 2024–2025
| Dec 2025 | Dec 2024 | |
|---|---|---|
| Operating Activities | ||
| Operating Cash Flow | -13.8M | -12.5M |
| Depreciation & Amort. | 5,000 | 6,000 |
| Investing Activities | ||
| Capital Expenditure | 0 | 0 |
| Free Cash Flow | -4.8M | -8.0M |
| Financing Activities | ||
| Dividends Paid | -61,000 | 0 |
| Stock Buybacks | — | — |
Cyclacel Pharmaceuticals, Inc. Cash Flow — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) cash flow over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGMS's cash flow history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s cash flow by year and by quarter, including the growth rate.